Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2008
11/20/2008WO2008030613A3 Hybrid suppressor trna for vertebrate cells
11/20/2008WO2008027241A3 Non-human embryonic stem cell lines and transgenic animals derived from them
11/20/2008WO2008005859A3 Dendritic cells generated using gm-csf and interferon alpha and loaded with heat-treated and killed cancer cells
11/20/2008WO2007143578A3 Perforin-2 proteins
11/20/2008WO2007130612A3 Method for obtaining and storing multipotent stem cells
11/20/2008WO2007127830A3 Dep2 and its uses in major depressive disorder and other related disorders
11/20/2008WO2007120541A3 Method for cloning and expression of nrui restriction endonuclease
11/20/2008WO2007112084A8 Method to modulate hematopoietic stem cell growth
11/20/2008WO2007103135A3 Active cell growth substrates and uses thereof
11/20/2008WO2007098267A3 Pseudoinfectious flavivirus and uses thereof
11/20/2008WO2007092299A3 Targeted conjugates and radiation
11/20/2008WO2006133052A3 A cellular therapy for ocular degeneration
11/20/2008WO2006121569A3 Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
11/20/2008WO2006062647A3 Gene expression and genetic changes implicated in alcoholism
11/20/2008WO2004087055A3 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation
11/20/2008US20080289067 Polypeptides having endoglucanase activity and polynucleotides encoding same
11/20/2008US20080289065 Peptide Aptamers That Bind to the Rep Proteins of Ssdna Viruses
11/20/2008US20080289062 Sorghum aluminum tolerance gene, SbMATE
11/20/2008US20080289058 Targeted delivery of glycine receptors to excitable cells
11/20/2008US20080289057 Sperm factor sequences
11/20/2008US20080289056 Aldolases, nucleic acids encoding them; improving thermal stability of enzyme; biosynthesis of atorvastatin, rosuvastatin, fluvastatin starting from e.g. acetaldehyde and chloroacetaldehyde, using enzyme 2-deoxyribose-5-phosphate aldolase (DERA) to form pyran intermediate
11/20/2008US20080289055 Melanoma antigens and their use in diagnostic and therapeutic methods
11/20/2008US20080289054 Fish Cancer Model
11/20/2008US20080287548 Compositions and Methods For Inhibiting an Isoform of Human Manganese Superoxide Dismutase
11/20/2008US20080287474 Antiproliferative Pyrimidyl, Fused Pyrimidyl and Pyrimidyl Hydrazones
11/20/2008US20080287471 4'-Substituted Carbovir And Abacavir-Derivatives As Well As Related Compounds With Hiv And Hcv Antiviral Activity
11/20/2008US20080287391 Cell Fusion Promoter and Utilization of the Same
11/20/2008US20080287388 Human G-Protein Coupled Receptor
11/20/2008US20080287384 Methods of Identifying Agents Having Antiangiogenic Activity
11/20/2008US20080287380 Antisense Oligonucleotides Against Cpla2, Compositions and Uses Thereof
11/20/2008US20080287374 Breast cancer-resistant protein inhibitor
11/20/2008US20080287364 Bitter Taste Receptors
11/20/2008US20080287358 Regulatory T Cell Mediator Proteins and Uses Thereof
11/20/2008US20080287356 Chimeric Proteins, Their Preparation and Pharmaceutical Compositions Containing Them
11/20/2008US20080287354 Pure polypeptides, neural prosaposin receptor proteins; controlled release and liposome formulations; oral, topical, and injectable administration; Parkinson's and Alzheimer's Diseases, retinal neuropathy, amyotrophic lateral sclerosis
11/20/2008US20080287349 Fibroblast growth factor 20 and methods of use thereof
11/20/2008US20080287348 Soluble Hybrid Prion Proteins And Their Use In The Diagnosis, Prevention And Treatment Of Transmissible Spongiform Encephalopathies
11/20/2008US20080287342 Compositions Comprising Modified Collagen and Uses Therefor
11/20/2008US20080287311 Membrane-Translocating Peptides
11/20/2008US20080287310 Human Sweet and Umami Taste Receptor Variants
11/20/2008US20080287309 Methods for Discovering Antibodies Specific to Cancer Cells and Antibodies Discovered Thereby
11/20/2008US20080286868 Metal binding compounds and their use in cell culture medium compositions
11/20/2008US20080286867 Method of Inducing Embryonic Stem Cells Into Pancreatic Cells
11/20/2008US20080286865 Methods for the Preservation of Platelet Efficacy During Storage
11/20/2008US20080286864 Choroid Plexus Preparation and Uses Thereof
11/20/2008US20080286863 Method and solutions for cryopreserving oocytes, especially fresh human oocytes
11/20/2008US20080286862 Physiochemical Culture Conditions for Embryonic Stem Cells
11/20/2008US20080286861 Compositions and Methods for the Treatment of Immune Related Diseases
11/20/2008US20080286850 Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
11/20/2008US20080286836 Retroviral gene transfer element for enhancement of heterologous gene sequences in cells
11/20/2008US20080286834 Leader Sequences For Directing Secretion of Polypeptides and Methods For Production Thereof
11/20/2008US20080286828 Materials and methods relating to g-protein coupled receptor oligomers
11/20/2008US20080286824 System for Screening Cells for High Expression of a Protein of Interest (Poi)
11/20/2008US20080286821 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2008US20080286817 Novel allergens and treatment
11/20/2008US20080286813 Antibody specific for mutant presenilin 1 and method of use thereof
11/20/2008US20080286805 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
11/20/2008US20080286804 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy
11/20/2008US20080286781 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
11/20/2008US20080286779 Host Cells Containing Multiple Integrating Vectors
11/20/2008US20080286770 DNA Molecules Encoding L-Glutamate-Gated Chloride Channels From Rhipicephalus Sanguineus
11/20/2008US20080286760 Means and Methods for the Determination of Camp In Vitro and In Vivo
11/20/2008US20080286759 Hepatocyte Bioreactor System For Long Term Culture of Functional Hepatocyte Spheroids
11/20/2008US20080286436 Delta-5 desaturase and its use in making polyunsaturated fatty acids
11/20/2008US20080286415 Proteases
11/20/2008US20080286389 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
11/20/2008US20080286366 mammal blood platelet containing polyethyleneimine ( PEI) based nanoparticles (prepared by incubating PEI with green fluorescent protein (GFP) plasmid DNA) containing an active agent such as antibacterial, antiviral agent, blood coagulation protein, gene etc. drug delivery to sites of vascular injury
11/20/2008US20080286345 Modified multilayered film
11/20/2008US20080286324 Media and devices for cold storage of therapeutic cells
11/20/2008US20080286323 Human Therapeutic Cells Secreting Nerve Growth Factor
11/20/2008US20080286316 Lipid raft, caveolin protein, and caveolar function modulation compounds and associated synthetic and therapeutic methods
11/20/2008US20080286315 Methionine Enkephalin as an Adjuvant for Vaccine Immunizations
11/20/2008US20080286314 Dendritic cells loaded with heat shocked melanoma cell bodies
11/20/2008US20080286312 Membrane-anchored beta2 microglobulincovalently linked to MHC class I peptide epitopes
11/20/2008US20080286305 Transgenic lymphocytic cells comprising nucleotide sequences which code tumor, bacterial and or viral antigens for use as tools in delivering vaccines to disease bearing tissues; drug delivery
11/20/2008US20080286304 Use of pre-viral DNA replication enveloped particles (PREPS) and/or L-particles for manufacture of a medicament for regulating leukocyte function; Cytotoxic T Lymphocytes
11/20/2008US20080286297 Chimeric Carrier Molecules for the Production of Mucosal Vaccines
11/20/2008US20080286295 Use of recombinant antigens to determine the immune status of an animal
11/20/2008US20080286293 Promiscuous pap cd4 t cell epitopes
11/20/2008US20080286292 Molecular vaccine linking intercellular spreading protein to an antigen
11/20/2008US20080286290 Anti-Cd14 Antibody Fusion Protein
11/20/2008US20080286288 Vascular endothelial growth factor 2
11/20/2008US20080286287 Methods and Agents for Modulating Cellular Activity
11/20/2008US20080286284 Compositions of PSMA antibodies
11/20/2008US20080286283 Treatment of cancer with antibodies to costimulating polypeptide of T cells
11/20/2008US20080286275 Antigen Binding Proteins Directed Against Scavenger Receptor B1 that Inhibit Hcv Replication
11/20/2008US20080286274 Vector for Efficient Selection and/or Maturation of an Antibody and Uses Thereof
11/20/2008US20080286271 Methods and Compositions for Modulating Tweak and Fn14 Activity
11/20/2008US20080286267 Methods for treating nervous system inquiry and disease
11/20/2008US20080286261 Methods of modulating hair growth
11/20/2008US20080286249 Use of mesenchymal stem cells for treating genetic diseases and disorders
11/20/2008US20080286248 Hiv Vif Mutants
11/20/2008US20080286247 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene
11/20/2008US20080286245 Preparation of regulatory t cells using icam-1 co-stimulation
11/20/2008US20080286243 Method For Isolation of a Hair Follicle Stem Cell and a Composition For Hair Reproduction
11/20/2008US20080286241 Transplantation of Differentiated Immature Adipocytes and Biodegradable Scaffold for Tissue Augmentation
11/20/2008US20080286228 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
11/20/2008US20080286198 Novel anti-IGF-IR antibodies and uses thereof
11/20/2008CA2687266A1 Means and methods for enhancing differentiation of haematopoietic progenitor cells
11/20/2008CA2687082A1 Improved feed media